COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC

NCT02484664 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Lymphangioleiomyomatosis (LAM)

Interventions

DRUG: Celecoxib

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]